The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

evita.no

Founded Year

1999

Stage

Acquired | Acquired

About e-vita

e-vita AS provides IT solutions for optimizing business processes and is a provider in Norway in portals and process solutions based on technology from Oracle. The company is also a specialized partner for databases and application grids. In addition, e-vita provides consulting services with expertise in the user experience, project management, system integration and administration.

e-vita Headquarter Location

Stortorvet 10

Oslo, NO-0155,

Norway

478 70 097

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

e-vita Patents

e-vita has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/27/2010

4/22/2014

Sensors, Biosensors, Biotechnology, Gas sensors, Transducers

Grant

Application Date

4/27/2010

Grant Date

4/22/2014

Title

Related Topics

Sensors, Biosensors, Biotechnology, Gas sensors, Transducers

Status

Grant

Latest e-vita News

CryoLife Wins EU CE Mark for E-vita Open NEO Hybrid Stent Graft

Mar 6, 2020

March 6th, 2020 CryoLife, Inc., a company based outside of Atlanta, Georgia, announced this week that it has received the European CE Mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease. Aortic arch disease encompasses both aortic aneurysms and aortic dissections, which occur suddenly and could be fatal. According to the release, about 7,000 patients are treated surgically for aortic arch disease annually in Europe, the Middle East, and Africa. Many patients with either an aneurysm or dissection in the aortic arch also present with a dissected or aneurysmal descending thoracic aorta. Often, these two conditions are addressed in a two-stage repair – one to repair the arch and the next to repair the descending thoracic aorta. CryoLife’s E-vita Open NEO enables surgeons to combine these two procedures into one, which allows patients to avoid a second surgery and provides a more cost-effective solution for hospitals. It is anticipated that the E-vita Open NEO will often be used in combination with JOTEC’s thoracic stent graft offering, E-nya. “We are pleased to have received CE Mark for E-vita Open NEO™, our newest hybrid stent graft technology for aortic arch and descending thoracic aorta repair,” said Pat Mackin, Chairman, President, and CEO of CryoLife, in a press statement. “This new design features a single tri-branched vessel that enhances ease-of-use and implantation that reduces surgical time and allows for a potentially safer procedure, thereby increasing the likelihood that more patients can benefit from the procedure and patient access to these therapies.”

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.